This is an antibody developed by antibody phage display technology using a human naive antibody gene library and human serum amyloid A1 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
Characteristics
This antibody can be detected with anti-mouse Fc secondary antibodies.
Purification
Protein A purification
Immunogen
No immunization, animal-free antibody development. Antigen: human serum amyloid A1
SAA1
Reactivity: Human
WB
Host: Rabbit
Polyclonal
unconjugated
Application Notes
ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody Optimal working dilution should be determined by the investigator
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, pH 7.4,
Storage
-20 °C
Target
SAA1
(Serum Amyloid A1 (SAA1))
Alternative Name
Serum Amyloid A1
Background
Serum Amyloid A1 (SAA1) is a prominent acute-phase protein in humans, primarily produced by the liver in response to inflammation. It plays a role in the immune system, potentially aiding in tissue repair, acting as an antibacterial agent, and signaling the migration of immune cells to sites of infection. Levels of SAA1 can increase dramatically (up to 1000-fold) during inflammatory states triggered by infections, injury, or chronic diseases.